[The effect of heparin on the lipid level during hemodialysis]. 1990

N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk

The level of free fatty acids, triglycerides, and total lipids was studied in dynamics during hemodialysis. At the beginning of hemodialysis, fatty acids are discharged into the blood flow and their level at 20 min of hemodialysis is three-fold the initial level. Plasma triglycerides, which are components of lipoproteins, are the source of the discharge of free fatty acids. This is confirmed by the fact that the triglyceride content reduces simultaneously with the increase in the level of free fatty acids. The concentration of total lipids practically does not change during hemodialysis. The possible significance of a sharp increase of the free fatty acid level during hemodialysis is discussed.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
May 1983, Casopis lekaru ceskych,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
December 1992, Minerva medica,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
January 2024, Seminars in nephrology,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
February 2001, Kidney international. Supplement,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
March 1981, Fortschritte der Medizin,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
January 1999, Nephron,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
December 1997, Clinical nephrology,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
November 1989, Therapeutic drug monitoring,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
January 1985, The Journal of laboratory and clinical medicine,
N P Nikolaeva, and V N Siniukhin, and A P Khokhlov, and I S Iarmolinskiĭ, and E A Stetsiuk
April 1984, Clinical nephrology,
Copied contents to your clipboard!